Genentech Resubmits Avastin sBLA For Metastatic Breast Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
The targeted oncologic is simultaneously approved in Europe for first-line treatment of patients with advanced non-small cell lung cancer.